5-140560716-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_133173.3(APBB3):c.955G>A(p.Ala319Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_133173.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APBB3 | NM_133173.3 | c.955G>A | p.Ala319Thr | missense_variant | 11/13 | ENST00000357560.9 | NP_573419.2 | |
APBB3 | NM_006051.4 | c.976G>A | p.Ala326Thr | missense_variant | 11/13 | NP_006042.3 | ||
APBB3 | NM_133172.3 | c.970G>A | p.Ala324Thr | missense_variant | 10/12 | NP_573418.2 | ||
APBB3 | NM_133174.3 | c.949G>A | p.Ala317Thr | missense_variant | 10/12 | NP_573420.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APBB3 | ENST00000357560.9 | c.955G>A | p.Ala319Thr | missense_variant | 11/13 | 5 | NM_133173.3 | ENSP00000350171.4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251312Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135870
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461878Hom.: 0 Cov.: 36 AF XY: 0.0000206 AC XY: 15AN XY: 727244
GnomAD4 genome AF: 0.000125 AC: 19AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74332
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at